Pharmaceuticals & Biotechnology
Balance Sheet: Strong Balance Sheet.
Profitability: Recent profitability of 15% is a good sign.
Size: It is a very small market cap company. Risks of volatility, governance, sustained growth assumptions should be double checked.
Smart Money: Smart money is losing interest in the stock.
Momentum: Stock has a weak negative price momentum.
Technicals: SharesGuru indicator is Bearish.
Understand Vasundhara Rasayans ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Shareholder Name | Holding % |
---|---|
P & J CRETECHEM PRIVATE LIMITED | 61.98% |
GARG LEASING AND FINANCE PRIVATE LIMITED | 3.55% |
Distribution across major stakeholders
Distribution across major institutional holders
Valuation | |
---|---|
Market Cap | 88.61 Cr |
Price/Earnings (Trailing) | 15.37 |
Price/Sales (Trailing) | 2.31 |
EV/EBITDA | 10.76 |
Price/Free Cashflow | 20.3 |
MarketCap/EBT | 11.41 |
Fundamentals | |
---|---|
Revenue (TTM) | 38.05 Cr |
Rev. Growth (Yr) | 7.25% |
Rev. Growth (Qtr) | 15.91% |
Earnings (TTM) | 5.83 Cr |
Earnings Growth (Yr) | 5.18% |
Earnings Growth (Qtr) | 68.67% |
Profitability | |
---|---|
Operating Margin | 20.64% |
EBT Margin | 20.64% |
Return on Equity | 18.05% |
Return on Assets | 15.45% |
Free Cashflow Yield | 4.93% |
Investor Care | |
---|---|
Dividend Yield | 0.83% |
Dividend/Share (TTM) | 2 |
Diluted EPS (TTM) | 22.91 |
Financial Health | |
---|---|
Current Ratio | 7.75 |
Debt/Equity | 0.06 |
Debt/Cashflow | 3.1 |